Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01JMX
|
|||
| Former ID |
DIB013843
|
|||
| Drug Name |
INS-1
|
|||
| Synonyms |
Diabetes therapeutics, Insmed; Inositol phosphoglycans, Insmed; D-chiro-inositol, Insmed
Click to Show/Hide
|
|||
| Indication | Metabolic disorder [ICD-11: 5C50-5D2Z; ICD-10: E70-E90; ICD-9: 270-279] | Phase 2 | [1] | |
| Company |
Insmed Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glucose metabolism (Glucose metab) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00349726) Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants. U.S. National Institutes of Health. | |||
| REF 2 | Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and beta-cells. Am J Physiol Endocrinol Metab. 2012 April 15; 302(8): E932-E940. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.